These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Supercharging BRD4 with NUT in carcinoma. Eagen KP; French CA Oncogene; 2021 Feb; 40(8):1396-1408. PubMed ID: 33452461 [TBL] [Abstract][Full Text] [Related]
4. Chemical Screen Identifies Diverse and Novel Histone Deacetylase Inhibitors as Repressors of NUT Function: Implications for NUT Carcinoma Pathogenesis and Treatment. Shiota H; Alekseyenko AA; Wang ZA; Filic I; Knox TM; Luong NM; Huang Y; Scott DA; Jones KL; Gokhale PC; Lemieux ME; Cole PA; Kuroda MI; French CA Mol Cancer Res; 2021 Nov; 19(11):1818-1830. PubMed ID: 34285087 [TBL] [Abstract][Full Text] [Related]
5. Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma. Alekseyenko AA; Walsh EM; Zee BM; Pakozdi T; Hsi P; Lemieux ME; Dal Cin P; Ince TA; Kharchenko PV; Kuroda MI; French CA Proc Natl Acad Sci U S A; 2017 May; 114(21):E4184-E4192. PubMed ID: 28484033 [TBL] [Abstract][Full Text] [Related]
6. The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains. Alekseyenko AA; Walsh EM; Wang X; Grayson AR; Hsi PT; Kharchenko PV; Kuroda MI; French CA Genes Dev; 2015 Jul; 29(14):1507-23. PubMed ID: 26220994 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma. Zhang X; Zegar T; Lucas A; Morrison-Smith C; Knox T; French CA; Knapp S; Müller S; Siveke JT Oncogene; 2020 Jun; 39(24):4770-4779. PubMed ID: 32366905 [TBL] [Abstract][Full Text] [Related]
8. Mechanistic analysis of the role of bromodomain-containing protein 4 (BRD4) in BRD4-NUT oncoprotein-induced transcriptional activation. Wang R; You J J Biol Chem; 2015 Jan; 290(5):2744-58. PubMed ID: 25512383 [TBL] [Abstract][Full Text] [Related]
9. The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma. Durall RT; Huang J; Wojenski L; Huang Y; Gokhale PC; Leeper BA; Nash JO; Ballester PL; Davidson S; Shlien A; Sotirakis E; Bertaux F; Dubus V; Luo J; Wu CJ; Keskin DB; Eagen KP; Shapiro GI; French CA Cancer Res; 2023 Dec; 83(23):3846-3860. PubMed ID: 37819236 [TBL] [Abstract][Full Text] [Related]
10. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. French CA; Ramirez CL; Kolmakova J; Hickman TT; Cameron MJ; Thyne ME; Kutok JL; Toretsky JA; Tadavarthy AK; Kees UR; Fletcher JA; Aster JC Oncogene; 2008 Apr; 27(15):2237-42. PubMed ID: 17934517 [TBL] [Abstract][Full Text] [Related]
11. EZH2 Cooperates with BRD4-NUT to Drive NUT Carcinoma Growth by Silencing Key Tumor Suppressor Genes. Huang Y; Durall RT; Luong NM; Hertzler HJ; Huang J; Gokhale PC; Leeper BA; Persky NS; Root DE; Anekal PV; Montero Llopis PDLM; David CN; Kutok JL; Raimondi A; Saluja K; Luo J; Zahnow CA; Adane B; Stegmaier K; Hawkins CE; Ponne C; Le Q; Shapiro GI; Lemieux ME; Eagen KP; French CA Cancer Res; 2023 Dec; 83(23):3956-3973. PubMed ID: 37747726 [TBL] [Abstract][Full Text] [Related]
12. Structural mechanism of BRD4-NUT and p300 bipartite interaction in propagating aberrant gene transcription in chromatin in NUT carcinoma. Yu D; Liang Y; Kim C; Jaganathan A; Ji D; Han X; Yang X; Jia Y; Gu R; Wang C; Zhang Q; Cheung KL; Zhou MM; Zeng L Nat Commun; 2023 Jan; 14(1):378. PubMed ID: 36690674 [TBL] [Abstract][Full Text] [Related]
13. Perturbation of BRD4 protein function by BRD4-NUT protein abrogates cellular differentiation in NUT midline carcinoma. Yan J; Diaz J; Jiao J; Wang R; You J J Biol Chem; 2011 Aug; 286(31):27663-75. PubMed ID: 21652721 [TBL] [Abstract][Full Text] [Related]
14. Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains. Reynoird N; Schwartz BE; Delvecchio M; Sadoul K; Meyers D; Mukherjee C; Caron C; Kimura H; Rousseaux S; Cole PA; Panne D; French CA; Khochbin S EMBO J; 2010 Sep; 29(17):2943-52. PubMed ID: 20676058 [TBL] [Abstract][Full Text] [Related]
15. miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4. Gen Y; Muramatsu T; Inoue J; Inazawa J Cancer Res; 2021 Oct; 81(20):5190-5201. PubMed ID: 34353856 [TBL] [Abstract][Full Text] [Related]
16. Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma. Thompson-Wicking K; Francis RW; Stirnweiss A; Ferrari E; Welch MD; Baker E; Murch AR; Gout AM; Carter KW; Charles AK; Phillips MB; Kees UR; Beesley AH Oncogene; 2013 Sep; 32(39):4664-74. PubMed ID: 23128391 [TBL] [Abstract][Full Text] [Related]
17. Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma. Wang R; Liu W; Helfer CM; Bradner JE; Hornick JL; Janicki SM; French CA; You J Cancer Res; 2014 Jun; 74(12):3332-43. PubMed ID: 24736545 [TBL] [Abstract][Full Text] [Related]
18. Zheng D; Elnegiry AA; Luo C; Bendahou MA; Xie L; Bell D; Takahashi Y; Hanna E; Mias GI; Tsoi MF; Gu B Life Sci Alliance; 2024 Jul; 7(7):. PubMed ID: 38724194 [TBL] [Abstract][Full Text] [Related]
19. [Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract]. Fang W; French CA; Cameron MJ; Han YD; Liu HG Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):519-24. PubMed ID: 23157742 [TBL] [Abstract][Full Text] [Related]